ENDODIAGNOSIS BLOG
Restorative Reproductive Medicine for Healthcare Professionals
More and more women are discovering Restorative Reproductive Medicine (RRM)—a personalized, science-based approach to fertility and gynecologic care that’s been helping women for decades. At FertilityCare Calgary, Maria and her team have supported hundreds of women in achieving pregnancy naturally by identifying and treating the root causes of infertility and reproductive health issues. RRM empowers women through cycle tracking, diagnostic testing, and collaborative treatment plans. Unlike artificial reproductive technologies that bypass the body, RRM works with it—offering real answers, not just short-term fixes.
Endosure Predictive Modeling Endometriosis Detection – Why is a Pain Score Used?
Dr. Mark Noar highlights the significance of using a pain score in the EndoSure predictive modeling for endometriosis detection, highlighting the evidence-based approach that combines subjective pain assessments with objective diagnostic measures. It also explains the historical context of endometriosis diagnosis, the role of prostaglandins in symptom manifestation, and the accuracy improvements achieved by incorporating pain scores into the diagnostic model.
Breaking the Silence: A New Frontier in Endometriosis Diagnosis
For Callina Artymko, years of unexplained pain and infertility finally made sense after taking the EndoSure test—a groundbreaking non-invasive diagnostic tool for endometriosis. Approved by Health Canada, EndoSure detects a unique biomarker in just 30 minutes, offering clarity where once there was only confusion. With early detection, women gain the power to make informed treatment decisions and avoid years of suffering. As access expands across Canada, EndoSure could finally close the diagnostic gap for the 1 in 10 women silently affected by this debilitating disease.
Hope for Rapid, Non-Invasive Endometriosis Diagnosis
A breakthrough in women’s health: The ENDOSURE test delivers 99.87% accurate, non-invasive results for endometriosis in under an hour, potentially transforming care and cutting years off diagnosis time. Despite its Health Canada approval, access remains limited. Clinicians and advocates urge wider adoption to reduce delays, improve outcomes, and support early intervention for the 1 in 10 women affected. EndoDiagnosis aims to bring access to testing to patients and clinics across Canada.